He W et al. -Greater than 50% of breast cancer patients discontinue adjuvant hormone therapy. Predictors of resuming treatment after discontinuation of adjuvant hormone therapy were determined. In the current study, resuming adjuvant hormone therapy was associated with better breast cancer outcomes.